Cargando…
Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
Introduction: An elevated heart rate is associated with an increased risk of death or cardiac transplant in children with dilated cardiomyopathy (DCM). Whether heart rate is a clinical marker to address therapy, is poorly investigated in children. Aim: To investigate the relationship between heart r...
Autores principales: | Adorisio, Rachele, Pontrelli, Giuseppe, Cantarutti, Nicoletta, Bellettini, Elisa, Caiazza, Martina, Mencarelli, Erica, Limongelli, Giuseppe, Poli, Daniela, Drago, Fabrizio, Kirk, Richard, Amodeo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757159/ https://www.ncbi.nlm.nih.gov/pubmed/36531178 http://dx.doi.org/10.3389/fphys.2022.1001752 |
Ejemplares similares
-
Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function
por: Adorisio, Rachele, et al.
Publicado: (2022) -
Duchenne Dilated Cardiomyopathy: Cardiac Management from Prevention to Advanced Cardiovascular Therapies
por: Adorisio, Rachele, et al.
Publicado: (2020) -
(577) Parvovirus B19 Myocarditis in a Covid19 MIS-C Syndrome: Cause or Causality?
por: Bellettini, E., et al.
Publicado: (2023) -
ICD Outcome in Pediatric Cardiomyopathies
por: Silvetti, Massimo Stefano, et al.
Publicado: (2022) -
The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)